To investigate the antitumor effect of the pharmacologic inhibition of PRMT5 on STS, a panel of seven cell lines representative of several histologic subtypes were treated with increasing concentrations of GSK595 for 10 days. The gene discussed is PRMT5; the disease is telomere syndrome.